Gregory A. Kaltsas
Expertise in
27
conditions

Gregory A. Kaltsas

75 Mikras Asias Street, 
Athens, ESYE31, GR 
Expertise in
27
conditions
75 Mikras Asias Street, 
Athens, ESYE31, GR 

Overview

Gregory Kaltsas practices in Athens, Greece. Mr. Kaltsas is highly rated in 27 conditions, according to our data. His top areas of expertise are Neuroendocrine Tumor, Adrenal Cancer, Adrenal Gland Adenoma, Parathyroidectomy, and Hepato-Pancreato-Biliary Surgery.

His clinical research consists of co-authoring 242 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender

Male

Locations

75 Mikras Asias Street, Athens, ESYE31 11567, Greece

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

An Open-label Extension Study of Levoketoconazole (2S,4R-ketoconazole) in the Treatment of Endogenous Cushing's Syndrome
An Open-label Extension Study of Levoketoconazole (2S,4R-ketoconazole) in the Treatment of Endogenous Cushing's Syndrome
Enrollment Status: Completed
Publish Date: June 19, 2025
Intervention Type: Drug
Study Drug: Levoketoconazole
Study Phase: Phase 3
A Double-blind, Placebo-Controlled, Randomized Withdrawal Following Open Label Therapy Study to Assess the Safety and Efficacy of Levoketoconazole (2S, 4R-ketoconazole) in the Treatment of Endogenous Cushing's Syndrome
A Double-blind, Placebo-Controlled, Randomized Withdrawal Following Open Label Therapy Study to Assess the Safety and Efficacy of Levoketoconazole (2S, 4R-ketoconazole) in the Treatment of Endogenous Cushing's Syndrome
Enrollment Status: Completed
Publish Date: November 08, 2022
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

242 Total Publications

Correction: Patients with Langerhans cell histiocytosis and hypothalamic-pituitary involvement: insights from the HEROS study cohort.
Correction: Patients with Langerhans cell histiocytosis and hypothalamic-pituitary involvement: insights from the HEROS study cohort.
Journal: Pituitary
Published: March 25, 2026

Frequently Asked Questions about Gregory A. Kaltsas

Is Gregory A. Kaltsas a top-rated expert for Neuroendocrine Tumor?

MediFind is an objective health platform that identifies experts based on real-world data. Gregory A. Kaltsas is classified as an Elite expert for Neuroendocrine Tumor, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Gregory A. Kaltsas participate in research or clinical trials?

Yes. Gregory A. Kaltsas has published 242 articles and abstracts on conditions like Neuroendocrine Tumor. You can view a list of Gregory A. Kaltsas's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Kaltsas's expertise for a condition
ConditionClose
View All 21 Advanced Conditions
View All 69 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile